Kenvue Inc. $KVUE Stock Position Lifted by Beacon Investment Advisory Services Inc.

Key Points

• Beacon Investment Advisory Services Inc. increased its stake in Kenvue Inc. by 7.1% in Q2, now holding 279,682 shares worth approximately $5.85 million.
• Analysts have given Kenvue a consensus rating of "Hold" with a price target averaging $23.32, despite some downgrades from firms like UBS and Barclays.
• Kenvue declared a quarterly dividend of $0.2075 per share, slightly up from the previous dividend, resulting in an annual yield of 4.9%.

Beacon Investment Advisory Services Inc. grew its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 7.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 279,682 shares of the company's stock after buying an additional 18,604 shares during the period. Beacon Investment Advisory Services Inc.'s holdings in Kenvue were worth $5,854,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of KVUE. Pittenger & Anderson Inc. bought a new position in Kenvue during the 1st quarter worth approximately $30,000. TruNorth Capital Management LLC acquired a new stake in shares of Kenvue during the 1st quarter worth approximately $36,000. Truvestments Capital LLC acquired a new stake in shares of Kenvue during the 1st quarter worth approximately $37,000. Clal Insurance Enterprises Holdings Ltd raised its position in shares of Kenvue by 378.5% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after purchasing an additional 1,287 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich raised its position in shares of Kenvue by 120.6% during the 1st quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company's stock worth $41,000 after purchasing an additional 929 shares during the period. Institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. UBS Group dropped their price target on Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Barclays dropped their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 15th. Citigroup reiterated a "neutral" rating on shares of Kenvue in a research report on Tuesday. Zacks Research upgraded Kenvue to a "strong sell" rating in a research report on Monday, August 11th. Finally, Canaccord Genuity Group dropped their price target on Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Four investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $23.32.

Kenvue Stock Down 2.2%

KVUE opened at $16.86 on Thursday. Kenvue Inc. has a 12 month low of $16.53 and a 12 month high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The stock has a market cap of $32.35 billion, a P/E ratio of 22.78, a P/E/G ratio of 2.48 and a beta of 0.83. The stock's 50 day moving average price is $20.59 and its 200 day moving average price is $21.93.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm had revenue of $3.84 billion for the quarter, compared to analysts' expectations of $3.94 billion. During the same period last year, the firm earned $0.32 EPS. The firm's revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue's payout ratio is 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.